🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Updated 04 Jul 2026 · HPRA open data

Opella Healthcare France SAS T/A Sanofi — Licensed Medicines

20 medicines held by Opella Healthcare France SAS T/A Sanofi on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 20 products held by Opella Healthcare France SAS T/A Sanofi
MedicineActive substanceLicence holderStatus
Bisolvon 4mg/5ml Oral Solution
PA23180/015/001
Bromhexine hydrochloride Opella Healthcare France SAS T/A Sanofi Not marketed
Buscopan 10 mg Coated Tablets
PA23180/016/002
Hyoscine butylbromide Opella Healthcare France SAS T/A Sanofi Marketed
Buscopan Ampoules 20 mg/ml Solution for Injection
PA23180/016/001
Hyoscine butylbromide Opella Healthcare France SAS T/A Sanofi Marketed
Buscopan Rx 10mg Coated Tablets
PA23180/022/001
Hyoscine butylbromide Opella Healthcare France SAS T/A Sanofi Not marketed
Dulcolax 10 mg Suppositories
PA23180/018/002
Bisacodyl Opella Healthcare France SAS T/A Sanofi Marketed
Dulcolax 5mg Gastro-resistant Tablets
PA23180/018/003
Bisacodyl Opella Healthcare France SAS T/A Sanofi Marketed
Dulcolax Pico Liquid 5 mg/5 ml oral solution
PA23180/017/001
Sodium picosulfate Opella Healthcare France SAS T/A Sanofi Marketed
Maalox 200mg/175mg per 5ml Oral Suspension
PA23180/009/001
Magnesium hydroxide, Aluminium hydroxide Opella Healthcare France SAS T/A Sanofi Marketed
Maalox 400mg/400mg Chewable Tablets
PA23180/009/002
Magnesium hydroxide, Aluminium oxide, hydrated Opella Healthcare France SAS T/A Sanofi Marketed
Maalox Plus 200 mg/175 mg/25 mg Oral Suspension
PA23180/008/001
Aluminium hydroxide, Magnesium hydroxide, Simeticone Opella Healthcare France SAS T/A Sanofi Marketed
Maalox Plus Chewable Tablets 200 mg/200 mg/25 mg
PA23180/008/002
ALUMINIUM OXIDE, HYDRATED PH. EUR, MAGNESIUM HYDROXIDE PH. EUR., Dimeticone ph. eur. (as simeticone ph. eur.) Opella Healthcare France SAS T/A Sanofi Marketed
NASACORT 55 micrograms/dose, nasal spray, suspension
PA23180/001/001
Triamcinolone acetonide Opella Healthcare France SAS T/A Sanofi Marketed
Nasacort Allergy 55 micrograms/dose nasal spray, suspension
PA23180/001/002
Triamcinolone acetonide Opella Healthcare France SAS T/A Sanofi Marketed
Phenergan 25 mg film-coated tablets
PA23180/011/002
Promethazine hydrochloride Opella Healthcare France SAS T/A Sanofi Marketed
Phenergan 5 mg/5 ml oral solution
PA23180/011/001
Promethazine hydrochloride Opella Healthcare France SAS T/A Sanofi Marketed
Selsun Shampoo 2.5% w/v
PA23180/013/001
Selenium disulfide Opella Healthcare France SAS T/A Sanofi Not marketed
Telfast 120 mg film-coated tablets
PA23180/003/002
Fexofenadine hydrochloride Opella Healthcare France SAS T/A Sanofi Marketed
Telfast 180 mg film-coated tablets
PA23180/003/003
Fexofenadine hydrochloride Opella Healthcare France SAS T/A Sanofi Marketed
Telfast 30 mg film-coated tablets
PA23180/003/001
Fexofenadine hydrochloride Opella Healthcare France SAS T/A Sanofi Not marketed
Telfast Allergy 120 mg film-coated tablets
PA23180/014/001
Fexofenadine hydrochloride Opella Healthcare France SAS T/A Sanofi Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 21 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.